Abstract:Unlike organ transplants where an immunosuppressive environment is required, a successful pregnancy involves an extremely robust, dynamic, and responsive maternal immune system to maintain the development of the fetus. A specific set of hormones and cytokines are associated with a particular stage of pregnancy. Any disturbance that alters this fine balance could compromise the development and function of the placenta. Although there are numerous underlying causes of pregnancy-related complications, untimely activation of Toll-like receptors (TLR), primarily TLR4, by intrauterine microbes poses the greatest risk. TLR4 is an important Pattern Recognition Receptor (PRR), which activates both innate and adaptive immune cells. TLR4 activation by LPS or DAMPs leads to the production of pro-inflammatory cytokines via the MyD88 dependent or independent pathway. Immune cells modulate the materno–fetal interface by TLR4-mediated cytokine production, which changes at different stages of pregnancy. In most pregnancy disorders, such as PTB, PE, or placental malaria, the TLR4 expression is upregulated in immune cells or in maternal derived cells, leading to the aberrant production of pro-inflammatory cytokines at the materno–fetal interface. Lack of functional TLR4 in mice has reduced the pro-inflammatory responses, leading to an improved pregnancy, which further strengthens the fact that abnormal TLR4 activation creates a hostile environment for the developing fetus. A recent study proposed that endothelial and perivascular stromal cells should interact with each other in order to maintain a homeostatic balance during TLR4-mediated inflammation. It has been reported that depleting immune cells or supplying anti-inflammatory cytokines can prevent PTB, PE, or fetal death. Blocking TLR4 signaling or its downstream molecule by inhibitors or antagonists has proven to improve pregnancy-related complications to some extent in clinical and animal models. To date, there has been a lack of knowledge regarding whether TLR4 accessories such as CD14 and MD-2 are important in pregnancy and whether these accessory molecules could be promising drug targets for combinatorial treatment of various pregnancy disorders. This review mainly focuses on the activation of TLR4 during pregnancy, its immunomodulatory functions, and the upcoming advancement in this field regarding the improvement of pregnancy-related issues by various therapeutic approaches.

TLRs induce Th1/Th2 responses by affecting the secretion of CCL2 at the maternal-foetal interface.

TLRs induce Th1/Th2 responses by affecting the secretion of CCL2 at the maternal-foetal interface

The decidual stromal cells-secreted CCL2 induces and maintains decidual leukocytes into Th2 bias in human early pregnancy.

Decreased Toll-like Receptor-2 Messenger Ribonucleic Acid and Increased Toll-like Receptor-4 in the Tubal Epithelium Next to the Infiltrated Trophoblasts During Tubal Pregnancy

Regulation of C-C Motif Chemokine Ligand 2 and Its Receptor in Human Decidual Stromal Cells by Pregnancy-Associated Hormones in Early Gestation.

Thymic Stromal Lymphopoietin from Trophoblasts Induces Dendritic Cell-Mediated Regulatory T(H)2 Bias in the Decidua During Early Gestation in Humans

Placental trophoblasts shifted Th1/Th2 balance toward Th2 and inhibited Th17 immunity at fetomaternal interface.

The Effect of Trophoblasts on T Lymphocytes: Possible Regulatory Effector Molecules - A Proteomic Analysis

Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders

Embryonic Trophoblasts Induce Decidual Regulatory T Cell Differentiation and Maternal–Fetal Tolerance Through Thymic Stromal Lymphopoietin Instructing Dendritic Cells

Trophoblasts-derived Chemokine CCL24 Promotes the Proliferation, Growth and Apoptosis of Decidual Stromal Cells in Human Early Pregnancy.

Expression and Functional Characterization of Nod2 in Decidual Stromal Cells Isolated During the First Trimester of Pregnancy

Expression and function of toll-like receptors at the maternal-fetal interface

CCL2: An important cytokine in normal and pathological pregnancies: A review

Decidual stromal cell-derived IL-33 contributes to Th2 bias and inhibits decidual NK cell cytotoxicity through NF-κB signaling in human early pregnancy.

Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy complications

Expression of chemokine CCL2 and its receptor CCR2 in decidua and decidual stromal cells of human first trimester gestation

Insight Into TLR4-Mediated Immunomodulation in Normal Pregnancy and Related Disorders

Human Trophoblast Cells Induced MDSCs from Peripheral Blood CD14+ Myelomonocytic Cells Via Elevated Levels of CCL2

Role of CCL17 and CCL22 expression in dendritic cells in maternal-fetal immune tolerance

Modulatory Effects of Trophoblast-Secreted CXCL12 on the Migration and Invasion of Human First-Trimester Decidual Epithelial Cells Are Mediated by CXCR4 Rather Than CXCR7